Abstract

The use of thiazolidinediones, drugs for type 2 diabetes that may also be useful for other chronic inflammatory disorders, is limited by fluid retention. Research in mice identifies a mechanism for this side effect and introduces a potential remedy (pages 861-866).

Original languageEnglish
Pages (from-to)822-824
Number of pages3
JournalNature medicine
Volume11
Issue number8
DOIs
StatePublished - Aug 1 2005

Fingerprint Dive into the research topics of 'TZDs and diabetes: Testing the waters'. Together they form a unique fingerprint.

  • Cite this